Wells Fargo
ONCR

Wells Fargo’s Oncorus, Inc. ONCR Stock Holding History

Wells Fargo’s Portfolio ONCR Stock Details ONCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-135
Closed -$46 – 7745
2023
Q1 		$46 Buy
135
+2
+2% +$1 ﹤0.01% 7134
2022
Q4 		$34 Buy
133
+4
+3% +$2 ﹤0.01% 7130
2022
Q3 		$0 Buy
129
+16
+14% +$21 ﹤0.01% 7741
2022
Q2 		$0 Sell
113
-1,683
-94% -$2.29K ﹤0.01% 7837
2022
Q1 		$3K Sell
1,796
-7,231
-80% -$20.3K ﹤0.01% 6626
2021
Q4 		$47K Buy
+9,027
New +$69.9K ﹤0.01% 6003
2021
Q3 		– Sell
-198
Closed -$3K – 7766
2021
Q2 		$3K Sell
198
-2,160
-92% -$33.4K ﹤0.01% 6498
2021
Q1 		$33K Sell
2,358
-1,088
-32% -$22.5K ﹤0.01% 6002
2020
Q4 		$111K Buy
+3,446
New +$79.8K ﹤0.01% 5320

Other funds holding ONCR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
YAL
Your Advocates Ltd Houston, Texas $350M AUM 21.03% 1-Year Est. Return

Wells Fargo's ONCR Position: Q2 2023 in Review

Wells Fargo sold out of Oncorus, Inc. (ONCR) in Q2 2023, closing a stake of 135 shares — an estimated $46 sold.

Wells Fargo first reported a position in ONCR in Q4 2020 and held it in 9 quarters. The position peaked at $111K in Q4 2020. 4 funds tracked by Wall St. Rank hold ONCR as of Q2 2023.

  • Wells Fargo reported no remaining Oncorus, Inc. position as of Q2 2023 after selling out during the quarter.
  • Wells Fargo sold 135 Oncorus, Inc. shares in Q2 2023, an estimated $46.
  • Wells Fargo first reported a position in Oncorus, Inc. in Q4 2020 and held it in 9 quarters.
  • Wells Fargo's Oncorus, Inc. position peaked at $111K in Q4 2020.
  • 4 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q2 2023.

Based on Wells Fargo's 13F filing for Q2 2023, filed 15 Aug 2023.